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The aim of this thesis was to develop new techniques for quantification of bovine pro-
inflammatory markers, with emphasis on cytokines and acute phase proteins, and to apply 
the techniques, using mastitis as disease model.  
 
Singleplex, duplex and triplex xMAP assays were developed for the bovine cytokines 
tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and the 
bovine acute phase proteins serum amyloid A (SAA) and lipopolysaccharide binding 
protein (LBP). Detection limits, linear ranges and intra- and inter-assay variations differed 
between assays, but generally, lower detection limits and wider linear ranges were observed 
in singleplex assays than in duplex and triplex assays. The detection limits for TNF-α, IL-
1β and IL-6 were satisfactory in the singleplex assays. Further development work is 
required before the multiplex formats can be used in assays where very low cytokine 
concentrations are of interest. In the assays for acute phase proteins the detection limits and 
linear ranges were satisfactory, but could probably be further improved. 
All xMAP assays could be used for quantification of the analytes in milk and plasma 
samples from cows with experimentally induced Escherichia coli or Staphylococcus aureus 
mastitis. Simultaneous detection of IL-1β, SAA and LBP was performed in plasma. LBP is 
secreted solely during bacterial infections, and cytokines and acute phase proteins are 
secreted at different phases of the inflammation. Thus a time perspective and information 
whether the infection is of bacterial origin or not is provided by measuring IL-1β, SAA and 
LBP simultaneously.  
  
In one of the studies, ten cows were grouped as high or low responders for TNF-α, IL-1β 
and IL-6, based on their cytokine response in an ex vivo whole blood stimulation assay 
(WBA) with lipopolysaccharide (LPS) and E. coli. After the WBA, the cows were 
intramammary inoculated with E. coli, and the WBA was evaluated for its usefulness as a 
predictive tool of the severity of E. coli mastitis. The pre-inoculation WBA with used 
stimulation doses and incubation times could not predict the severity of an E. coli induced 
mastitis. 
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The most exciting phrase to hear in science, 
the one that heralds the most discoveries, 
is not "Eureka!" but "Hm… that's funny..." 
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Abbreviations 
 
The following abbreviations will be used in the text: 
 
ANCOVA    Analysis  of  covariance 
APC        Antigen  presenting  cell 
APP       Acute  phase  protein 
BSA        Bovine  serum  albumin 
CD         Cluster  of  differentiation 
CFU        Colony  forming  units 
C V          C o e f f i c i e n t   o f   v a r i a t i o n    
DMEM       Dulbecco’s  modified Eagle’s medium 
E. coli      Escherichia coli 
EDC        1-ethyl-3-(3-dimethylaminopropyl)  carbodiimide  hydrochloride 
ELISA       Enzyme-linked  immunosorbent  assay 
GLM        General  linear  model 
I L         I n t e r l e u k i n  
LBP       LPS-binding  protein 
LOD        Limit  of  detection 
LPS       Lipopolysaccharide 
LTA        Lipoteichoic  acid 
MFI       Mean  fluorescence  intensity 
MHC        Major  histocompatibility  complex 
PAMP      Pattern-associated  molecular  pattern   
PBS       Phosphate  buffered  saline 
P E          P h y c o e r y t h r i n  
pi          Post  inoculation 
PGN        Peptidoglycan 
rboIL-6       Recombinant  bovine  IL-6 
rboSAA       Recombinant  bovine  SAA 
rboTNF-α      Recombinant  bovine  TNF-α 
rhuLBP       Recombinant  human  LBP 
rhuTNF-α      Recombinant  human  TNF-α 
rovIL-1β      Recombinant  ovine  IL-1β 
rovTNF-α      Recombinant  ovine  TNF-α 
S. aureus      Staphylococcus aureus 
SAA        Serum  Amyloid  A 
SCC       Somatic  cell  count 
SD         Standard  deviation 
Sulfo-NHS     N-hydroxysulfosuccinimide  
TLR       Toll-like  receptor 
TNF-α       Tumour  necrosis  factor-α 
T r i s          T r i s - b u f f e r e d   s a l i n e  
WBA        Whole  blood  stimulation  assay 
 
 
   9 
Introduction 
Bovine infectious diseases, especially mastitis, generate considerable animal 
welfare problems and economical losses in the dairy industry worldwide and 
further investigations on preventive measures, diagnostic methods and alternatives 
for treatment are therefore needed. Knowledge of the innate immune response in 
general and of the early host response to intramammary pathogen invasion is 
essential. By mapping different inflammatory markers, the progress of an infection 
can be studied in detail. The ability to characterize and quantify cytokines and 
acute phase proteins (APPs) is fundamental to understand the inflammatory 
responses to infectious diseases.  
 
 
Bovine infectious diseases 
The term infectious diseases did not exist in early human communities (Last, 
1998). Although fatal diseases, such as smallpox and plague, spread through the 
world and people died en masse, connections were not drawn between an 
individual’s survival of a disease and resistance to the same disease during the 
next outbreak. It was not until the tenth century that Chinese physicians observed 
that a patient obtained immunity after survival of a smallpox infection and used 
that knowledge for a first vaccination attempt (Gross & Sepkowitz, 1998). They 
developed a method, variolation, where they dried material from smallpox scabs 
and induced a mild smallpox infection. The technique spread and it had reached 
the whole civilized world by the 1750s (Feery, 1976; Barquet & Domingo, 1997).  
Inspired by the progress in human immunology, veterinarians in 1754 started to 
inoculate cows with mild forms of cattle plague successfully inducing resistance 
(Tizard, 2004). During the nineteenth century, epochal advances in immunological 
research in both animal and man were achieved by e.g. Edward Jenner, Louis 
Pasteur and Daniel Elmer Salmon constituting the fundamental knowledge about 
infectious diseases and the immunological response to them (Gross & Sepkowitz, 
1998; Last, 1998). 
 
Although research in the fields of immunology, microbiology, hygiene and 
nutrition has led to eradication of several dangerous diseases, infectious diseases 
are still a large problem (BSE Inquiry: The Report, 2000). Infectious pneumonia 
with bovine respiratory syncytial virus (BRSV) and parainfluenza type 3 virus (PI-
3 virus) as important pathogens cause major fatalities in dairy calves worldwide 
(Bryson, 1985: Ames, 1997). Another important health problem in cattle is 
different diarrhoeal diseases, for example winter dysentery and diarrhoeas caused 
by bovine viral diarrhoea virus (BVDV) (Tråvén, 1993; Kalaycioglu, 2007). 
In Swedish cattle, diseases that are common in other parts of Europe, e.g. 
brucellosis,  Mycobacterium bovis, tuberculosis, foot-and-mouth disease and 
Johne’s disease are presently not found (Herlin, Hultgren & Ekman, 2007). With 
continuously increasing travelling and more flexible export- and import laws for 
animals within Europe, the risks of transfer of unwanted disease pathogens to 
Sweden increase. Improved methods for early detection of such diseases are   10
therefore important so that programmes to prevent spreading of the pathogens can 
be effective.  
 
Mastitis 
Most cases of bovine mastitis are of infectious origin, but trauma, physical injury 
and hyper-active lymphocytes have also been reported as reasons for mastitis 
(Tournant, 1995; Bradely, 2002). It is found in a clinical form, characterized by 
local and systemic signs of inflammation and infection, and in a sub-clinical form, 
where the milk quality and quantity are deteriorated but clinical symptoms are 
absent. Most clinical cases of mastitis are acute, while the sub-clinical form of the 
disease frequently becomes chronic (Barkema, Schukken & Zadoks, 2006). 
Depending on the degree of local and systemic signs during acute clinical forms of 
mastitis, the disease is ranked as mild, moderate or severe (Wenz et al., 2001). 
Severe cases of acute clinical mastitis can be fatal if left untreated (Eberhart, 
1984). Despite extensive research on preventive strategies, control programs and 
treatments of mastitis during the last decades (Eberhart, 1986; Ziv, 1992; du Preez, 
2000), it is still considered the most important production disease in cattle of 
developed countries. That is because of the economic consequences for the 
farmers, due to unacceptable milk quality and low quantity, veterinary costs, and 
culling (Rajala-Schultz & Gröhn, 1999; Seegers, Fourichon & Beaudeau, 2003). 
 
Henceforth, attention will be focused on different forms of infectious mastitis. 
Bovine infectious mastitis can be caused by innumerable pathogens. Since the late 
1800s, streptococci have been associated with mastitis (Jones, 2005), and by the 
mid-1900s it was well-established among veterinarians that infectious mastitis 
could be caused by e.g.  staphylococci,  streptococci, coliform bacteria and 
mycobacteria (Norcross & Stark, 1970; Schultze, Stroud & Brasso, 1985). Since 
then the list has grown to include mycoplasma, virus, yeast and algae. However, 
bacterial infections are still the major cause (Bradley, 2002; Wellenberg, van der 
Poel & van Oirschot, 2002). 
   Contagious pathogenic bacteria live and multiply in infected mammary glands 
and can spread from one udder quarter to another within an udder, or from cow to 
cow. This group of bacteria includes the Gram-positive Staphylococcus aureus (S. 
aureus), Streptococcus agalactiae and several mycoplasma and Arcanobacterium 
species (Bradley, 2002; Kerro-Dego, van Dijk & Nederbragt, 2002). Another 
group of pathogenic bacteria is present in the animals’ environment and they 
usually invade the mammary gland by teat contamination. This group of bacteria 
includes the Gram-negative Escherichia coli (E. coli) and Klebsiella pneumoniae, 
the Gram-positive Streptococcus dysgalactiae ( S.  dysgalactiae),  Streptococcus 
uberis, and different Bacillus species (Kerro-Dego, van Dijk & Nederbragt, 2002; 
Persson Waller & Unnerstad, 2004). In Sweden, the yearly incidence of infectious 
mastitis is about 60%, with most cases being sub-clinical (Swedish Dairy 
Association, 2007). The most prevalent pathogens, together explaining about half 
of all reported mastitis cases, are S. aureus and S. dysgalactiae. Another important 
pathogen, responsible for the most severe cases of clinical mastitis is E. coli.  
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Udder infections can occur at any time during a cows’ lactation cycle, but higher 
prevalence of infections with environmental pathogens such as E. coli are 
observed around drying-off and calving (Burvenich et al., 2003; Rajala-Schultz, 
Hogan & Smith, 2005; Burvenich et al., 2007). Also, the parity number seems to 
be associated with the susceptibility and severity of clinical mastitis (Gilbert et al., 
1993; Vangroenweghe, Lamote & Burvenich, 2005). The variation in 
susceptibility to udder pathogens is associated with the status of the cow and her 
immune system. Pregnancy, calving, induction of milk production and drying-off 
are periods of considerable challenge to the body. These periods involve tissue 
remodelling and changed nutritional demands which affect the functions of the 
immune system, making it less capable of fighting infections (Burvenich, et al., 
2003, 2007; de Schepper et al., 2008).  
 
 
Innate immunity and innate immune responses 
The primary task of the immune system is to protect the host from environmental 
microbes that threatens it. In general, the immune system is characterized by its 
capacity to recognize and discriminate between self and non-self (Tizard, 2004). 
The host is protected by two forms of immune defence mechanisms, the innate and 
the acquired immunity, that interact closely to eliminate foreign invaders and 
protect the host. In the innate immunity, non-specific mechanisms recognise and 
kill microorganisms, while responses of the acquired immunity are specific, 
leading to selective elimination of pathogens. In addition, repeated exposure to the 
same antigen amplifies the immune responses of the acquired immune system, i.e. 
the responses are adaptive. Innate immune mechanisms dominate the early stages 
of an infection while later stages are characterized by actions of the acquired 
immunity. In this thesis, attention is focused on the induction of the innate immune 
response. 
 
The first obstacle microbial invaders have to conquer before they can settle in a 
host is the anatomical and physical barriers of the body (Tizard, 2004). The skin 
and the mucosal membranes of the respiratory and gastro-intestinal tract constitute 
the basic physical defence barriers. The individual tries to remove the intruder by 
coughing, sneezing, vomiting and diarrhoea, but given time a persistent invader 
often overcomes the physical hindrances. If microorganisms manage to enter the 
body, the first line of immunological defence, the innate immune system, becomes 
activated (Chinen & Shearer, 2007; Opitz et al., 2007).  
In the innate immune system, phagocytic cells (e.g. neutrophils, monocytes and 
macrophages) together with natural killer (NK) cells, act as constant surveyors of 
the body, scanning for invaders (Tracey, 2002). When an attack is encountered, a 
localized inflammatory response is initiated. Inflammation is a local defence 
mechanism aiming to remove invading agents or initiate a healing process of 
damaged tissue. That is performed by enhanced blood flow to the site of invasion, 
locally increasing the quantity of phagocytic cells that can attack and destroy the 
invaders. Increased blood flow to the inflammatory site also accumulates other 
antimicrobial factors such as complement components and antibodies at the site of 
inflammation (Goldsby et al., 2003). Neutrophils and macrophages are the major   12
phagocytic cells of the body, whereas NK-cells recognise and lyse cells without 
major histocompatibility complex (MHC) class I molecules on their surface 
(Tizard, 2004). Actions of the acquired immune system are initiated by antigen 
presenting cells (APC) displaying parts of invading organisms on their cell-surface 
receptors. Three major cell types act as APC, macrophages, dendritic cells and B-
lymphocytes. The antigen presentation activates the functional cells of the 
acquired immunity, the lymphocytes. B-lymphocytes produce antibodies against 
invading microorganisms, helper-T-cells regulate the immune response and 
cytotoxic T-cells kill virally infected cells and cells without MHC class I on their 
surface (Tizard, 2004).     
 
The alterations observed during acute inflammatory responses are mediated 
through release of various inflammatory mediators, foremost cytokines (Koj, 
1996; Ebersole & Cappelli, 2000; Tracey, 2002). Cytokines involved in the 
inflammatory response can roughly be divided into three subgroups: (i) pro-
inflammatory cytokines, that initiate and enhance the cascade of events; (ii) 
interleukin (IL)-6-type cytokines, that induce the systemic actions; (iii) anti-
inflammatory cytokines, that down-regulate the inflammatory response. Important 
mediators in the group of pro-inflammatory cytokines are tumour necrosis factor 
(TNF)-α, IL-1β and IL-8. Among the IL-6-type cytokines, IL-6 is a prominent 
actor, but leukaemia inhibitory factor, IL-11, oncostatin M and cardiotrophin-1 are 
also important members of this group. In the set of down-regulating cytokines IL-
4, IL-10, IL-13 and transforming growth factor (TGF)-β have prominent roles. 
A wide variety of cells produce cytokines when activated by different stimuli, 
but macrophages are the dominant producers of the pro-inflammatory cytokines 
TNF-α, IL-1β and IL-6 (Tizard, 2004). The main functions of TNF-α, IL-1β and 
IL-6 are to induce the acute phase response, i.e. starting inflammatory processes 
such as production of APPs in the liver, attracting neutrophils to the site of 
inflammation, and activating B-, T- and NK-cells (Moshage, 1997; Goldsby et al., 
2003; Petersen, Nielsen & Heegaard, 2004). The initiation of the acute phase 
response is described in Figure 1. 
   
Figure 1. The cytokine-mediated activation of the acute phase response. When 
macrophages are exposed to stimulating agents they start to produce cytokines that act on 
neighbouring cells (monocytes, neutrophils, lymphocytes and endothelial cells). These cells 
become activated and produce more cytokines and express different membrane-bound 
receptors. Endothelial cells express selectins (black boxes) which attract circulating 
leukocytes and platelets from the bloodstream to the site of inflammation. Cytokines 
released into the bloodstream induce the hepatic acute phase response which involves 
increased synthesis of APPs. The cytokines also stimulate the central nervous system to e.g. 
induce fever (Modified from Jensen & Whitehead, 1998). 
 
APPs are produced by hepatocytes, and their blood plasma concentration increases 
(positive APPs) or decreases (negative APPs) by at least 25% during inflammatory 
responses (Morley & Kushner, 1982). The positive APPs are produced within a 
few hours of injury and aid in eradication of pathogens and in wound healing by 
acting as components in clotting factors, as well as protease inhibitors and metal-
binding proteins (Ramadori & Armbrust, 2001). Circulating IL-6 is believed to 
play the most important role in induction of APP production and the IL-6 
synthesis is regulated by TNF-α and IL-1β. Thus, APP production could be 
considered a synergistic action of those cytokines (Heinrich, Castell & Andus, 
1990; Akira, Taga & Kishimoto, 1993). The major functions of the pro-
inflammatory cytokines and APPs in early innate immune responses are listed in 
Table 1.  
The concentrations of the major APPs, C-reactive protein (CRP), serum amyloid 
A (SAA) and haptoglobin increase massively after cytokine stimulation of 
hepatocytes in many species (Gruys et al., 2005; Ceciliani, Giordani & Spagnolo, 
2002). The expression levels of the APPs differ, however, from species to species, 
proteins considered major APPs in one species might not be relevant in another 
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(Ceciliani, Giordano & Spagnolo, 2002; Tizard, 2004). In cows, haptoglobin, 
SAA and α1-acid glycoprotein are major APPs, while CRP concentrations not are 
correlated to inflammatory responses in cows (Petersen, Nielsen & Heegaard, 
2004). 
 
Table 1. Origin and some functions performed by a few important mediators during early 
innate immune responses to infections. Some of the functions described are performed 
synergistically by more than one cytokine. Information is compiled from Petersen, Nielsen 
& Heegaard (2004); Tizard (2004 and Horst Ibelgaufts’ COPE with cytokines (2008). 
 
Cytokine  Major source  Important activities in inflammation 
 
Tumour necrosis 
factor-α (TNF-α) 
 
 
 
Interleukin-1β (IL-1β)  
 
 
 
 
Interleukin-6 (IL-6)  
 
 
 
 
Interleukin-8 (IL-8) 
 
Macrophages 
Monocytes 
Neutrophils 
Lymphocytes 
 
Monocytes 
 
 
 
 
Monocytes 
Fibroblasts 
Endothelial cells 
 
 
Monocytes 
Macrophages 
Fibroblasts 
 
 
Chemoattractant for neutrophils 
Inducing IL-1β and IL-6 
Enhancing B- and T-cell proliferation 
 
 
Chemoattractant for neutrophils 
Stimulating B-, T-and NK-cells 
Inducing IL-6, IL-8 and APP 
Inhibiting TNF-α, IL-1β, IL-6 
 
Inducing APP production 
Aiding in B-cell differentiation 
Stimulating B- and T-cells 
Inhibiting TNF-α, IL-1β, IL-6 
 
Activating neutrophilic oxidative burst 
Chemoattractant for all known 
migratory immune cells   
 
Acute phase protein  Major source  Important activities in inflammation 
 
C reactive protein (CRP) 
 
 
 
Haptoglobin 
 
 
Lipopolysaccharide 
binding protein (LBP) 
 
Serum Amyloid A (SAA) 
 
 
 
Hepatocytes 
 
 
 
Hepatocytes 
 
 
Hepatocytes 
 
 
Hepatocytes 
 
Activating monocytes, macrophages 
and the complement system 
Inducing production of IL-1 
 
Binding haemoglobin 
Inhibiting oxidative burst of neutrophils 
 
Facilitating binding of PAMPs to TLRs 
 
 
Inhibiting fever, oxidative burst of    
neutrophils and platelet functions 
Chemoattractant for leukocytes 
 
The innate immune system recognizes a great number of different pathogens by 
locating highly conserved motifs shared by several pathogens. These motifs are 
commonly referred to as pathogen-associated molecular patterns (PAMPs), and 
include e.g. mannose, double-stranded RNA, cytosine-guanine-rich DNA, and the 
bacterial cell wall constituents lipopolysaccharide (LPS), peptidoglycan (PGN), 
and lipoteichoic acid (LTA) (Aderem & Ulevitch, 2000; Zeytun et al., 2007). 
Cells of the immune system utilize evolutionary conserved pattern recognition receptors, Toll-like receptors (TLRs), for recognition of PAMPs. At least ten 
functional TLRs have been identified in mammals, where each receptor has 
specificity for PAMPs in bacteria, viruses, fungi or parasites (Chen et al., 2007). 
Interaction between PAMPs and TLRs on the immune cells induces production of 
cytokines and other immunological mediators that are important in elimination of 
pathogenic microorganisms.  
A component of the Gram-negative bacterial cell wall is LPS, a component not 
found in Gram-positive bacteria, where instead PGN is the major component. 
PGN can also be found to a lesser extent in the walls of Gram-negative bacteria. 
(Trent et al., 2006) (Figure 2). LPS is recognized by the host mainly through TLR-
4, and PGN is detected by TLR-2 (Underhill, 2003). The TLRs are however not 
capable of inducing inflammatory responses on their own, but need help from 
other immune-recognition proteins. Both LPS and PGN recognition is associated 
with the soluble protein lipopolysaccharide binding protein (LBP), and the 
membrane bound proteins CD14 and MD-2 (Dziarski, R., Tapping, R.I. & Tobias 
1998; Dziarski & Gupta, 2000; Beutler, 2000, Weber et al., 2003). Although TLR-
4 and TLR-2 elicit different intracellular signalling cascades and therefore 
different immune responses, the production of pro-inflammatory cytokines is 
induced by both TLRs (Werling & Jungi, 2003; Bannerman et al., 2004). 
 
 
 
Figure 2. Construction of the cell walls of Gram-negative (left) and Gram-positive (right) 
bacteria. The peptidoglycan layer is thicker in walls of Gram-positive bacteria than in walls 
of Gram-negative bacteria, where instead lipopolysaccharide (LPS) is found in the outer 
membrane (Modified from www.gsbs.utmb.edu/microbook, Jan-11, 2008). 
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Innate immune responses to bacterial mastitis 
During clinical mastitis the cardinal symptoms of inflammation i.e. redness, heat 
and swelling can be observed locally in the udder. The animals often show signs 
of pain, loss of appetite, fever, increased heart- and respiration rates, diarrhoea, 
slow reticulo-rumen motility and weakened skin turgor can be present (Lohuis et 
al., 1988; Vangroenweghe et al., 2005). Other important clinical manifestations 
are considerably reduced milk yield and changed milk composition (Shuster et al., 
1991; Rajala-Schultz et al., 1999). The clinical symptoms during mastitis have 
mainly been explained by the immune mediated shock and the extensive 
inflammatory process, and not so much by the invading pathogen (Dosogne et al., 
2002; Hoeben et al., 2000; Burvenich et al., 2007). 
 
Ehrlich (1892) was first to report presence of antibodies in milk. He suggested that 
the mammary gland functioned as a reservoir for antibodies, but had no capacity to 
produce them. Today it is well established that the mammary gland has substantial 
immunological capacity, which is of cardinal importance in the defence against 
pathogenic udder invasion. The basic defence mechanisms include anatomical, 
cellular and soluble factors that act in coordination and are crucial for mammary 
gland resistance to bacterial invasion (reviewed by Oviedo-Boyso et al., 2007). 
During lactating periods, the flushing of milk physically hinders infection and in 
addition, the milk contains antimicrobial substances such as complement 
components, lactoferrin, lactoperoxidase and thiocyanate ions, together with 
different immune cells (Tizard, 2004).  
Macrophages, lymphocytes, neutrophils and epithelial cells are the cell types 
found in healthy milk. The macrophages are the dominant celltype, guarding the 
gland against intruders (Paape et al., 2000 & 2003). In addition, the antibody 
subsets IgA and IgG1 are present in milk. IgA is synthesized locally in the udder 
and IgG1 is actively transferred there from serum (Tizard, 2004). The 
concentrations of IgA and IgG1 in milk are, due to the continuous milk flow, 
unfortunately not high enough to exert adequate protective influence.  
 
When bacteria colonize the udder and start proliferating, PAMPs, e.g. LPS, PGN 
and LTA, are released from dead bacteria. These PAMPs are caught on TLRs on 
macrophages in the mammary gland. The macrophages internally process their 
PAMPs, become activated and start to launch the acute mammary inflammatory 
response as well as activating the adapted immunity. The macrophages perform 
this by secreting e.g. complement factors, TNF-α, IL-1β, IL-6, IL-8, and 
arachidonic acid metabolites such as leukotrienes, prostaglandins and platelet 
activating factor (Tizard, 2004). These mediators guide leukocytes, mainly 
neutrophils, from blood to the affected mammary gland (Rainard & Riollet, 2006). 
In healthy mammary glands, the milk usually contains < 100000 cells/ml, a 
number that within hours of bacterial infection of the udder can increase to > 
1million cells/ml (Harmon, 1994).   
Neutrophils and macrophages in the udder ingest and kill pathogens by different 
means  e.g. by production of reactive oxygen intermediates, reactive nitrogen 
intermediates, hydrolytic enzymes and defensins that all are toxic for devoured 
pathogens (Paape et al., 1979; Tizard, 2004). Neutrophils are the major effector cells in bovine innate and adaptive immunity and have been extensively studied 
(reviews by Paape et al., 2000, 2003; Rainard & Riollet, 2006, Lun et al., 2007). 
In order to be effective during bovine mastitis, neutrophils have to migrate rapidly 
to the site of infection and start to phagocyte and kill bacteria immediately (Paape 
et al., 2003). Neutrophils can only ingest and kill a limited number of pathogens 
before they undergo apoptosis, while macrophages can ingest and kill numerous 
particles during their longer life-span (Paape et al., 2000). 
The release of pro-inflammatory cytokines during bacterial mammary gland 
infections also affects the acquired immune system by activating B- and T-
lymphocytes. Also, as mentioned before TNF-α, IL-1β and IL-6 are responsible 
for the systemic symptoms such as fever, lethargy, malaise, loss of appetite and 
weight loss seen during some forms of mastitis, in addition with the induction of 
APP production (Tizard, 2004). (Figure 3). 
 
 
Figure 3. A brief overview of the major mechanisms induced by TNF-α, IL-1β and IL-6 
during the host response to microbial mammary gland infection. 
 
Methods to study innate immune responses 
Different methods to describe, quantify and grade immune responses have been 
developed (Masseyeff, 1991; Ferré, 1994; Eckersall et al., 1999; Sachdeva & 
Asthana, 2007). The first mediator in the group later called cytokines was 
described in the 1950s (Isaacs & Lindenmann, 1957). Since then, molecular 
characterization of many cytokines has been performed and their functions have 
been described (Ryan & Majno, 1977; Sikora, 1980; Dinarello, 2000). The 
cytokine family is continuously expanding and different cytokines have become 
useful tools for diagnosis and treatment of bovine immunological diseases 
(Lofthouse  et al., 1996; Moore, 1996; Wood & Jones, 2001). Also, APPs 
frequently serve as markers of inflammation and infection in various species and 
diseases (reviewed by e.g. Petersen et al., 2004). In cattle, quantification of APPs 
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in blood plasma, especially SAA and haptoglobin, have been shown to 
discriminate between acute and chronic inflammatory conditions (Horadagoda et 
al., 1999; Eckersall et al., 2001). 
 
Quantification of cytokines and APPs 
Under normal circumstances cytokines are undetectable or found in very low 
levels in body fluids and tissues (Sachdeva & Asthana, 2007), but high levels can 
be found early in the inflammatory process. Since different cytokines can be 
related to specific groups of pathogens it is valuable to quantify them as early as 
possible. A wide range of assays for detection of cytokines in different biological 
samples are available. Depending on the type of information required, different 
ways to detect the cytokines are used, some methods assess the biological activity, 
others the mRNA expression, and yet others the secretion of a cytokine or its 
soluble receptor.  
Cytokines and their soluble receptors are usually analysed in body fluids and 
cell-supernatants with Enzyme-Linked Immunosorbent Assay (ELISA), 
Radioimmunoassays (RIA), chemiluminescence or bioassays. When the cytokine 
production from specific cell populations or individual cells are of interest, 
methods such as multi-parametric flow cytometry, different mRNA-based assays 
(reverse-transcriptase linked polymerase chain reaction (RT-PCR), Northern 
blotting, In situ hybridisation (ISH), RNA-protection assays), intra-cytoplasmic 
cytokine staining, and Enzyme-Linked Immunospot (ELISPOT) can be used. To 
detect presence of cytokines in tissues, immunostaining and different mRNA 
based assays usually are performed. Each assay has its advantages and limitations. 
Standard ELISA is for instance not suited for high throughput analyses since it 
only measures one analyte at the time, and RT-PCR, which can be performed in 
multiplex style, measure gene expression and not the proteins.  
Coming technologies for cytokine quantification seem to be in multiplex 
formats, i.e. several cytokines are analysed simultaneously in the same sample. 
Examples of multiplex technologies are multiplex ELISA, DNA- and protein 
micro-arrays and microsphere-based multiplex flow cytometric assays (Grøndahl-
Hansen, et al., 2003; Wilson et al., 2005; Andersson et al., 2007). Simultaneous 
assessment of several cytokines in a biological sample is probably more valuable 
than measuring the absolute concentrations of a single component, since they act 
together (Ebersole & Cappelli, 2000; Sachdeva & Asthana, 2007).  
  
Unlike the cytokines, APPs can often be found in low levels in body fluids from 
healthy individuals of different species (Bannerman et al., 2003; Ledeu & Rifai, 
2003). The feature that makes them interesting as markers of inflammation and 
infection is their rapid elevation in blood plasma when the immune system is 
activated (Blackburn, 1994; Malle & DeBeer, 1996; Jensen & Whitehead, 1998; 
Heegard, et al., 2000). In cows with mastitis, hundredfold higher SAA plasma 
concentrations have been recorded compared to concentrations in healthy cows 
(Eckersall et al., 2001). Most frequently used assays for detection of bovine APPs 
are ELISA, mRNA based assays, bioassays and biosensor assays (Eckersall et al., 
1999, Åkerstedt et al., 2006). 
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Particle based flow cytometry 
Flow cytometry is a powerful and fast technique where fluorescent and light 
scattering properties of cells or particles are analyzed (Shapiro, 2003). Particles 
are lead through an illuminating beam of coherent light, usually originating from a 
laser. The scattered laser light and emitted fluorescence is translated to 
information about the cell. Flow cytometry can be used to analyse intracellular and 
surface properties of cells and particles, distinction between live and dead cells 
can be made and physical sorting of cells with interesting properties can be 
performed. 
 
In 1975 Knapp, et al. introduced antigen-coated microspheres with fluorescent 
labels as solid phase for capture and quantification of antigen-antibody reactions. 
That technique has been continuously improved and new applications have been 
found (Phillips et al., 1980; Wanda & Smith, 1982; MacCrindle, Schwenzer & 
Jolley 1985; Frengen et al., 1994). For instance, in 1982, Lisi et al. described a 
fluorescence immunoassay where diametrically different microspheres were used, 
enabling detection of different analytes in the same sample. In 1997 Fulton et al. 
presented the LabMAP technology (Luminex Corporation, Austin, TX, USA), 
presently called the xMAP technology. The new technique combines microsphere 
immunoassays, flow cytometry, rapid digital signal processing and multiplexing. 
Multiple analytes can individually and quantitatively be detected simultaneously in 
small volumes of samples with reliable statistics, as data are collected from at least 
100 microspheres for each analyte.  
Like in conventional immunoassays, the xMAP technique utilizes a solid and a 
soluble phase, where polystyrene microspheres function as the solid phase. 
Capture antibodies, often monoclonal, are covalently coupled to the microspheres, 
and the amount of bound analyte is determined with the use of fluorophore-
coupled detection antibodies. In order to translate fluorescence intensities to 
quantitative data, the microspheres are analysed in a dedicated flow cytometer. To 
allow multiplexing, different microsphere subsets are internally dyed with a mix of 
far red and infrared fluorophores, giving them unique identities (Figure 4). By 
coupling different monoclonal antibodies to different microsphere subsets, 
multiplexing is possible. The dedicated flow cytometer used for xMAP assays is 
equipped with two lasers, one for classification of microspheres and one for 
quantification of the amount of analyte in the sample. For classification, a red laser 
exciting the red and infrared dyes inside the microspheres is used, and for 
quantification, a green laser exciting the molecules attached to the reporter 
antibody, resulting in orange fluorescence, is used. 
 
                  
 
Figure 4. Basic principles of the xMAP technique. To the left, an example of a sandwich 
immunoassay performed on a microsphere is shown. Capture antibodies are covalently 
coupled to microspheres, the analyte of interest binds to the capture antibody and is 
detected by a fluorophore-coupled reporter antibody. Note the proportionally different 
scales of the microsphere and the antibodies bound to it, the antibodies should be 
considerably smaller. In the middle, the 100 unique subsets of internally dyed microspheres 
are illustrated and to the right the two lasers in the flow cytometer, one for classification of 
the microsphere and one for quantification of analyte are depicted (With permission from 
Breackmans et al., 2003).  
 
The microsphere subsets can either be purchased antibody-conjugated or 
conjugation-ready  i.e. covered with avidin, carboxyl groups or oligonucleotide 
adapters. When microspheres with carboxyl groups are utilized, covalent coupling 
is usually performed using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) and N-hydroxysulfosuccinimide (sulfo-NHS). EDC reacts 
with the carboxyl groups on the microspheres, forming amine-reactive 
intermediates which sulfo-NHS stabilizes by converting them to amine-reactive 
sulfo-NHS esters, thus increasing the efficiency of the coupling reaction (Staros, 
Wright & Swingle, 1986). 
 
Other multiplex particle based flow cytometric assays are available on the market. 
BD Biosciences (San Jose, CA, USA) has for instance developed the cytometric 
bead array (CBA), where microspheres with different fluorescence intensities from 
a single fluorophore are used for capture and quantification of soluble particles 
(Morgan  et al., 2004). Like the xMAP technique, an immunological sandwich 
assay is performed in the CBA. The main difference between the techniques, apart 
from the different internal colouring system, is that a dedicated flow cytometer is 
not necessary to carry out the CBA. Instead, it can be performed with any multi-
use flow cytometer.  
The xMAP
  technique comes with conjugation-ready microspheres and 
commercially available kits containing antibody-coupled microspheres and 
detection antibodies. The CBA technique only operates with commercially 
available kits. Kits are available for e.g. cytokines, phosphoproteins, cancer 
markers, lipoproteins and endocrine markers in human, mouse and rat samples. 
 
Since Carson & Vignali (1999) reported simultaneous detection of 15 murine 
cytokines in a single sample by the use of the xMAP technique, numerous studies 
on cytokines, inflammatory mediators, antibodies, growth factors and apoptotic 
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markers in various biological fluids in health and disease, have been performed 
with particle based flow cytometric assays (Cook et al., 2001; Kuller et al., 2005; 
Elshal & McCoy, 2006). Most studies have been focused on cytokines in human 
samples (Camilla et al., 2001; de Jager et al., 2005), but measurements have also, 
apart from the work in this thesis, been conducted in pigs, rodent and horses 
(Johannisson et al., 2006; Zhong et al., 2007; Go et al., 2008).  
The technique has become more versatile since the microspheres can be 
purchased carrying avidin, carboxyl groups or oligonucleotides. Studies on for 
instance genotyping, endocrine markers, allergens, enzymes and tumor markers in 
different species have been reported (Thrailkill et al., 2005; Dolezalova et al., 
2007; Haasnot & de Pré, 2007; Sun et al., 2007; Zhu & Salmeron, 2007).  
All new laboratory techniques must be evaluated on the reproducibility, 
precision and accuracy. This is usually performed by comparison to existing 
methods. Microsphere based flow cytometric assays have been compared to 
ELISA (Prabhakar, Eirikis & Davis, 2002; Thrailkill et al., 2005; Pang et al., 
2005; Elshal & McCoy, 2006; Lash et al., 2006). Conclusions from those studies 
are good correlation but poor concurrence of quantitative values between the 
assays. This is probably due to different antibody clones, blocking agents and 
detection systems in the different assays.      
 
The ex vivo whole blood stimulation assay (WBA) 
Cytokines are potent mediators of the immune system, and they are often only 
secreted transiently in low concentrations even during inflammatory states (Eskay, 
Grino & Chen, 1990; Bemelmans, van Tits & Buurman, 1996; Kelso, 1998). This 
makes detection of them in body fluids difficult. By stimulating whole blood 
samples with specific pathogens or fragments of pathogens ex vivo the 
immunological responsiveness in an individual can be monitored (Finch-Arietta & 
Cochran, 1991; Wouters et al., 2002). 
In whole blood stimulation assays (WBA), leukocytes are used in an 
environment mimicking their natural one. This has advantages compared to both 
in vitro and in vivo studies. Monocytes extracted from blood to be used in studies 
in vitro tend to become activated by handling (Desch et al., 1989; Allen et al., 
1992). Also, when monocytes are cultured in a medium, cytokines, receptors, 
hormones, metabolites and other components in the blood that naturally interact 
with the monocytes are lost. In the ex vivo assays, repeated challenges with 
different doses of endotoxin in samples from the same individual are possible, 
something that cannot be performed as easily during in vivo studies.  
Ex vivo WBA with LPS as the stimuli have been useful for measurements of 
TNF-α, IL-1β, and IL-6 responsiveness in healthy individuals of several species 
(Finch-Arietta & Cochran, 1991; Zangerle et al., 1992; Wouters et al., 2002; 
Carstensen, Røntved & Nielsen, 2005; Røntved et al., 2005). Several studies 
suggest that the severity of clinical symptoms during E. coli mastitis is correlated 
to the cows’ capacity of pro-inflammatory mediator production (reviewed by e.g. 
Burvenich  et  al., 2007). Investigations of the pro-inflammatory cytokine 
responsiveness to LPS could be valuable in terms of susceptibility analyses to 
Gram-negative bacterial infections.    22
During acute infections and active inflammatory diseases the production of TNF-
α, IL-1β and IL-6 has a pivotal role in initiating the immunological protection 
processes. It is however important that the production is closely regulated. High 
blood plasma concentrations of TNF-α have been associated with severe clinical 
mastitis and septic shock (Sordillo & Peel, 1992; Sordillo, Pighetti & Davis, 
1995). Cows with a balanced immune system stand a better chance to successfully 
eliminate pathogen invasion, for instance in the udder. Whether the differences in 
capacity to produce TNF-α after various stimuli in healthy individuals have a 
connection to the genetic background has been studied. Louis et al. (1998) showed 
that an individuals’ degree of TNF-α production is predisposed by genetic 
background, while de Jong et al. (2002) on the contrary showed that it is not. In a 
study performed on cows by Elsasser, Blum & Kahl (2005), the degree of TNF-α 
production after LPS stimulation was shown to be genetically regulated and also 
inheritable. 
Bovine ex vivo studies on TNF-α responsiveness to LPS have strengthened the 
WBAs’ usefulness for monitoring of the in vivo innate immune response (Elsasser, 
Blum & Kahl, 2005; Røntved et al., 2005). Therefore extended information about 
the immune function connected to mammary E. coli infections in cows could be 
gained by quantifying the responsiveness of TNF-α, IL-1β and IL-6 to LPS and E. 
coli. Also, if correlations between the responsiveness to TNF-α, IL-1β or IL-6 ex 
vivo and the severity of clinical E. coli mastitis could be established, the WBA 
may be used as a predictive tool for the severity of clinical mastitis in cows. The 
ability to predict the intensity of a response to different immunological challenges 
in livestock could also improve breeding programs, where TNF-α response data 
could be used to identify a genetic predisposition for a problem that could develop 
in calves of specific breeding lines.  
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Aims  
The overall aim of the present study was to develop new techniques for 
quantification of bovine pro-inflammatory markers, with emphasis on cytokines 
and APPs, and to apply the techniques, using mastitis as a disease model. 
 
The specific aims were:  
 
•  to investigate the ability of commercially available antibodies against 
human TNF-α to cross-react with bovine TNF-α using the xMAP 
technique. 
 
•  to investigate if the xMAP
 technique is suitable for quantification of the 
cytokines TNF-α, IL-1β and IL-6 in singleplex and multiplex assays in 
bovine samples. 
 
•  to apply the xMAP
 technique for TNF-α, IL-1β and IL-6 in studies on  
bovine milk and blood plasma samples from cows with mastitis. 
 
•  to evaluate if ex vivo LPS and E. coli induced production of TNF-α,  
IL-1β and IL-6 in blood samples from healthy cows can predict their 
immunological response after intramammary E. coli inoculation.  
 
•  to evaluate if concentrations of TNF-α, IL-1β and IL-6 in milk and blood 
plasma after intramammary E. coli inoculation are correlated to each 
other and to the severity of clinical signs. 
 
•  to investigate if the xMAP-technology is applicable for multiplex 
detection of the cytokine IL-1β and the acute phase proteins SAA and 
LBP in bovine biological samples. 
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Materials and methods 
In this section of the thesis material, methods and experimental procedures are 
summarized and commented. Details about the materials and methods used in 
Papers I-IV are described in each paper, respectively. 
 
Animals and infection models 
All experimental handling with animals were approved by the Ethical Committee 
for Animal Experiments, Uppsala, Sweden or by the Danish Animal Experiments 
Inspectorate. Milk somatic cell count (SCC) and milk yield was observed daily 
during all the experimental protocols. Systemic and local clinical signs were 
monitored in the cows. Systemic signs included general attitude, appetite, saliva 
secretion, rectal temperature, heart rate, respiration frequency, rumen contraction 
frequency, and signs of diarrhoea. The udder was inspected for signs of 
inflammation and the milk composition was analysed. Fresh milk was aseptically 
collected for bacterial examinations and SCC determination. Milk samples for 
analyses of APPs and cytokines were collected in test tubes, aliquoted and frozen 
in -20°C until use. Blood samples used for analyses of APPs and cytokines were 
aseptically aspired in EDTA vacuettes from the jugular veins of the cows and 
centrifuged at 4°C so plasma could be collected, aliquoted and frozen in -80°C. 
 
Paper I 
Samples with known concentrations of TNF-α from two different experimental 
studies were included in Paper I. Milk samples were obtained from a study in 
which six clinically healthy cows of the Swedish Red and White, and Swedish 
Holstein breeds had been intramammary inoculated with S. aureus (Grönlund et 
al., 2003).  Blood samples were obtained from another study, in which five Danish 
Holstein Friesian cows had been intravenously challenged with LPS from E. coli 
(Røntved et al., 2005). 
 
Paper II – III  
Milk and blood samples from ten high-yielding clinically healthy Danish Holstein 
cows in the midst of their first or second lactation, intramammary inoculated with 
live E. coli were used. The cows had a daily mean ± SD milk yield of 35 ± 5 kg 
and a SCC < 84000 cells/ml at the start of the experiment. In Paper II, blood and 
milk from six of the cows were included, while blood and milk samples from all 
ten cows were included in Paper III.  
 
Paper IV 
Blood plasma samples from two Danish Black and White cows were used. The 
udder of one cow had been inoculated with LPS from E. coli first and PGN from 
S. aureus two weeks later. The other cow was treated in the reverse order. The 
cows had a daily milk yield of 30 – 35 kg and a SCC < 110000 cells/ml at the start 
of the experiment.     25 
 
Laboratory analyses 
Bacterial growth and SCC in milk (Papers I – III) 
Bacterial analyses of milk were performed according to standard procedures at the 
Section of Mastitis, National Veterinary Institute, Uppsala, Sweden, and according 
to standard procedures at the Department of Animal Health, Welfare and 
Nutrition, Research Centre Foulum, Tjele, Denmark. SCC was determined in fresh 
milk samples by analysis with a fluorooptical method on a Fossomatic instrument 
(Foss Electric Ltd, Hillerød, Denmark). 
 
The xMAP assays  
Microspheres 
Different subsets of polystyrene microspheres (Ø 5.6 μm) with carboxyl groups on 
the surfaces, internally dyed with far red and infrared fluorophores, were used in 
all xMAP assays. In Papers I-II the microspheres were purchased from Luminex 
Corporation (Austin, TX, USA) and in Papers III - IV the microspheres originated 
from Bio-Rad Laboratories (Hercules, CA, USA).    
 
Antibodies and recombinant proteins 
In the xMAP
  assays, monoclonal antibodies against human TNF-α (Paper I), 
bovine TNF- α (Papers II –IV), ovine IL-1β (Papers II – IV), bovine IL-6 (Papers 
II – III), bovine SAA (Paper IV) and bovine LBP (Paper IV) were used. The 
polyclonal antibodies were directed against the same species except for IL-6 
which was directed against ovine IL-6. As standards were recombinant bovine 
TNF-α, ovine IL-1β, bovine IL-6, bovine SAA and human LBP applied.  
The anti-bovine LBP antibodies used in Paper IV are validated by the 
manufacturer (HyCult Biotechnology, Uden, The Netherlands) to cross-react with 
the recombinant human LBP used as standard. In addition, the same antibody 
clones have previously been employed in sandwich-format for detection of LBP in 
bovine samples (Bannerman et al., 2003). The antibodies against ovine IL-1β are 
guaranteed by the manufacturer (AbD Serotec, Oxford, England) to detect bovine 
IL-1β. The recombinant ovine IL-1β has earlier worked successfully as standard 
for IL-1β detection in bovine samples (Persson Waller et al., 2003). 
 
Coupling of antibodies to microspheres 
Before an xMAP assay was performed, antibodies were coupled to microspheres. 
The coupling was performed in two steps: (1) activation of the carboxyl groups on 
the microspheres using EDC and sulfo-NHS in sodium phosphate buffer (2) 
covalent coupling of antibodies to the microspheres. The antibody-coupled 
microspheres were kept protected from light at 2 – 8 ºC, until use. 
 
The Luminex 100 System 
In all xMAP assays, the Luminex 100 instrument and the Luminex XY platform 
from Luminex Corporation were utilized. The XY platform allows analyses to be 
performed in 96-well-plates instead of in single tubes. The settings for the   26
classification and quantification lasers were calibrated daily, using special 
calibration microspheres of known fluorescent light intensities (Bio-Rad 
Laboratories), when the laboratory work in Papers I – IV was performed. 
Validation of the optics, fluidics, reporter- and classification systems was 
performed every third month, as suggested by the manufacturer, also with special 
validation microspheres bought from Bio-Rad Laboratories. 
In Paper I, the software Luminex Data Collector 1.7 (Luminex Corporation) was 
used, while BioPlex Manager 4.0 (Bio-Rad Laboratories) was employed in Paper 
II - IV. Both softwares provide information on mean and median fluorescence 
intensity, standard deviations and number of microspheres of each subset in 
combination with data regression analysis. Analyte concentrations were obtained 
by interpolation from standard curves calculated with a five parametric regression 
model.  
 
Validation 
All singleplex and multiplex (duplex and triplex) xMAP assays used in the studies 
were optimised and validated before use. The concentrations of capture antibodies 
on the microspheres and the antibodies used for detection- and reporting were 
determined by titration. Limits of detections (LOD), linear ranges of the standard 
curves and intra- and inter-assay variations were calculated for the assays. Also, 
the recovery percentage of an analyte in milk and plasma as compared to buffer 
and cross-reactivity between the different analytes in the multiplex assays were 
studied.  
 
Quantification of TNF-α, IL-1β, IL-6, SAA and LBP (Paper I - IV) 
In Paper I, four milk and four serum samples from the S. aureus mastitis study and 
the LPS challenge study, respectively, were used. They were integrated as 
standards in a commercially available Fluorokine MAP kit (R&D Systems, 
Minneapolis, MN, USA) directed towards human TNF-α. In addition, the samples 
were used to test cross-reactivity with antibodies against human TNF-α in our lab. 
Milk and plasma samples collected from six cows at one occasion before, and 
one occasion after inoculation were used to validate singleplex and multiplex 
xMAP assays for TNF-α, IL-1β and IL-6 in Paper II. In Paper III, the singleplex 
assays developed in Paper II were used for quantification of IL-1β and IL-6 in the 
samples collected before and after inoculation of E. coli. In Paper IV, the plasma 
samples were analysed for their content of IL-1β, SAA and LBP using a triplex 
xMAP assay developed and validated in our lab.   
 
The ex vivo WBAs (Paper III) 
The WBA for bovine blood was developed and described by Røntved et al. 
(2005). In Paper III, a modified version where duplicate blood samples were 
incubated with Dulbecco’s Modified Eagle’s Medium (DMEM), phosphate 
buffered saline (PBS), LPS, heat-killed or live E. coli for 3.5 or 24 hours, was 
conducted. The WBA was carried out on two consecutive days before the start of 
the E. coli mastitis experiment and mean cytokine concentrations of the two days 
were calculated. Based on the concentrations of TNF-α, IL-1β and SAA after 
stimulation with LPS and live E. coli, the cows were grouped as high or low   27 
responders for each cytokine. The cows were ranked 1-10, and the cow with the 
highest cytokine response was ranked nr 1. For each cytokine, the cows ranked 1-
5 were grouped as high responders and the cows ranked 6-10 were grouped as low 
responders. The groups were used for further evaluation of differences in 
susceptibility to E. coli infection, severity of clinical symptoms, and cytokine 
concentrations in milk and plasma between the high and low responders. 
 
ELISA assay (Paper III) 
The ELISA used for quantification of TNF-α in blood samples from the ex vivo 
WBA and in all milk and plasma samples from the E. coli mastitis study was  
originally described by Ellis et al. (1993) and we used it with the modifications 
described by Røntved et al. (2005). 
 
 
Statistical analyses 
Data obtained from the Luminex 100 were evaluated with BioPlex Manager 4.0 
(Bio-Rad Laboratories) and data are presented as mean value ± standard deviation 
(SD) as interpolated from standard curves calculated with a five parametric 
regression model. The statistical calculations of obtained results were performed 
with Minitab 15 (Minitab Inc., Coventry, England) and Statistical Analysis 
Systems (SAS) 9.1 (SAS Institute Inc., Cary, NC, USA).  
 
A p-value < 0.05 was regarded as statistically significant in all studies, and all 
results shown are significant, unless something else is stated. 
 
Paper I 
The limit of detection (LOD), defined as the lowest concentration of each analyte 
that can be detected, was established for the different antibody clones in the 
xMAP and Fluorokine MAP assays. The mean fluorescence intensity (MFI) for 
six replicates containing microspheres coupled with capture antibodies against 
each analyte, detection antibodies against each analyte, and assay buffer was 
calculated, and LOD was defined as average MFI + 3 SD, as suggested by the 
International Conference on Harmonization (1994).  
Recovery percentages in serum and milk were determined by setting the MFI 
from experiments conducted in buffer to 100% and calculating the results from 
analyses of the same analytes in serum and milk as percentages ± SD. 
 
Papers II and IV  
LOD was established for all analytes in singleplex and multiplex xMAP
 assays, as 
described for Paper I with the modification that eight replicates was used. 
Differences between the LODs for each analyte were evaluated by paired 
Student’s t-test. Intra- and inter-assay coefficients of variation (CV’s) were 
calculated for each analyte by the formula: SD/mean x 100. 
Cross-reactivity between reagents included in the multiplex xMAP assays were 
evaluated by assays where different antibody-coupled microspheres directed 
against the different analytes in the multiplex assay were incubated with only one   28
antibody at the time. Paired Student’s t-tests were applied on these data. In Paper 
II, paired Student’s t-test was also applied on the data to examine whether 
equivalent results were achieved using singleplex and triplex xMAP assays. 
 
Paper III  
In the WBA, the effects of different stimuli ex vivo on the cytokine concentrations 
in blood samples were analysed with a non-parametric multiple comparison test 
with randomized block design, the Friedman’s test. Differences in cytokine 
concentrations due to incubation time and different E. coli doses were evaluated 
with a non-parametric two-sample rank test, a Mann-Whitney U test in the WBA. 
Based on the results obtained in the WBA, the cows were grouped as high (H) and 
low (L) responders for each cytokine, and differences in severity of clinical 
symptoms and concentrations of cytokines in milk or plasma were analysed with 
Mann-Whitney’s U test. 
Pre-inoculation mean values ± SD was determined for heart rate, respiration, 
milk yield and SCC. The pre-inoculation mean value ± 2 SD was considered 
normal and values above or below were considered abnormal. The effect of time 
post inoculation (pi) on concentrations of milk and blood cytokine concentrations 
were analysed with the Friedman test. A general linear model analysis of 
covariance (ANCOVA) where time pi and within-cow covariance were 
compensated for was used for determination of associations between cytokine 
concentrations in milk and plasma pi and clinical signs, and between cytokine 
concentrations in milk and plasma, respectively. In order to do statistical analyses 
of the data, which not was normally distributed, data was transformed to a Poisson 
distribution prior to analysis. 
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Results 
Development of xMAP assays (Papers I, II and IV) 
Singleplex xMAP assays for TNF-α, IL-1β, IL-6, SAA and LBP were developed 
and successfully applied for detection of the analytes in milk and blood samples 
from cows with mastitis, using ovine and bovine reagents. In addition, duplex 
assays for simultaneous detection of IL-1β and IL-6, TNF-α and IL-1β, or TNF-
α and IL-6 as well as triplex assays for simultaneous detection of TNF-α, IL-1β 
and IL-6 or IL-1β, SAA and LBP were developed and used for detection of the 
analytes in bovine milk and blood samples. 
  
Antibody clones cross-reacting between species 
All antibody clones directed against human TNF-α evaluated in Paper I could 
detect recombinant human TNF-α (rhuTNF-α) using the xMAP assay. Two 
antibody clones, Mab11 (BD Pharmingen, San Diego, CA, USA) and 6401.1111 
(BD Biosciences, San Diego, CA, USA), could also detect recombinant ovine 
TNF-α (rovTNF-α) in concentrations greater than 2.5ng/ml. None of the antibody 
clones tested could, however, detect TNF-α in bovine milk or serum samples. The 
Fluorokine MAP-kit from R&D Systems detected very low concentrations (about 
4 pg/ml) of rhuTNF-α from two different sources, R&D Systems and AbD 
Serotec. RovTNF-α could, however, not be detected with the Fluorokine MAP-kit, 
nor could TNF-α in the bovine milk and serum samples with known 
concentrations of TNF-α. 
 
Singleplex and multiplex xMAP assays 
In Paper II singleplex, duplex and triplex xMAP assays for TNF-α, IL-1β and IL-
6 were developed, validated and used for detection of cytokines in milk and 
plasma from cows with mastitis. In singleplex assays the LODs for TNF-α, IL-1β 
and IL-6 were 0.5, 0.08 and 0.2 ng/ml, respectively. Corresponding LODs in the 
triplex assay were 3.5, 2.0 and 6.5 ng/ml.  
In Paper IV, singleplex and triplex xMAP assays were designed, validated and 
applied for detection of IL-1β, SAA and LBP in plasma samples from cows with 
mastitis. LODs were for IL-1β, SAA and LBP 0.1, 2.0 and 1.0 ng/ml, respectively, 
in the singleplex assays, and 0.4, 3.8 and 0.8 ng/ml in the triplex assay. A selection 
of the intra- and inter-assay coefficients of variation (CV’s) obtained for the 
different xMAP assays developed in Paper II and IV are shown in Table 2. 
   30
Table 2. Intra- and inter-assay variations of singleplex (A) and triplex (B) xMAP assays of 
rovIL-1β, rboIL-6, rboTNF-α, rboSAA and rhuLBP. Samples with 25, 100 or 200 ng/ml of 
recombinant analyte were analysed.  
 
 
A 
 
Intra- assay 
  
Inter-assay 
 
Analytes 
 
Mean (ng/ml) 
 
SD 
 
CV (%) 
  
Mean (ng/ml) 
 
SD 
 
CV (%) 
             
rboTNF-α 114.2  1.7  1.5   218.2  11.1  5.1 
rovIL-1β
1 123.1  4.8  3.9    24.6  3.5  14.2 
rovIL-1β
2 23.7  1.0  4.1   28.3  4.1  14.6 
rboIL-6 86.9  9.3  10.7    185.0  37.2  20.1 
rboSAA 29.1  5.3  18.0    24.4  5.2  21.4 
rhuLBP 25.7  4.0  15.5    31.5  6.4  20.4 
              
B Intra-  assay    Inter-assay 
 
Analytes 
 
Mean (ng/ml) 
 
SD 
 
CV (%) 
  
Mean (ng/ml) 
 
SD 
 
CV (%) 
              
rboTNF-α 127.4  7.9  6.2   195.3  17.2  8.8 
rovIL-1β
1 131.1  27.8  21.2    21.5  8.5  39.6 
rovIL-1β
2 25.6  0.8  3.2   23.9  1.6  6.6 
rboIL-6 92.6  21.5  23.2    174.2  66.2  38.0 
rboSAA 24.7  1.5  6.0    25.8  5.1  19.8 
rhuLBP 27.7  2.1  7.7    20.1  4.2  20.7 
 
 
1IL-1β evaluated in Paper II, 
2IL-1β evaluated in Paper IV. 
 
In Paper I, rhuTNF-α was added to bovine milk and serum samples and the 
recovery could be detected using the Fluorokine MAP-kit. In milk, the recovery 
was 59.8 ± 2.0% while it in plasma was 36.4 ± 1.6%. That suggests that 
components of the matrix interfere with the antibody assay. Also during the 
development work for Papers II and IV interference due to matrices was observed.  
 
Reliable standard curves could be produced for all the above mentioned analytes 
in both singleplex and multiplex assays. The linear ranges of the curves varied 
between the analytes and for all of them the range was wider in singleplex assays 
than in multiplex assays. Standard curves from the two triplex assays (TNF-α, IL-
1β, IL-6 and IL-1β, SAA, LBP, respectively) are shown in Figure 5. 10
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Figure 5. Mean fluorescence intensities of representative standard curves of triplex xMAP 
assays for recombinant bovine TNF-α, recombinant ovine IL-1β, and recombinant bovine 
IL-6 at the top. At the bottom are standard curves for recombinant ovine IL-1β, 
recombinant bovine SAA, and recombinant human LBP shown. 
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Experimental E. coli mastitis (Paper III)  
Six of ten cows became infected and developed moderate clinical mastitis after the 
E. coli inoculation. Detectable concentrations of E. coli bacteria were found in all 
infected mammary gland quarters pi. Fever and reduced daily milk yield were 
observed in all infected cows. Looser faeces consistency was observed at least 
once in all cows, both infected and non-infected. Local symptoms of the udder, 
such as redness, swelling, elevated SCC, changed milk colour and composition, 
were recorded in all infected cows from 18 hours pi until the end of the study. 
Also the non-infected cows showed sporadically elevated SCC pi.  
 
Concentrations of TNF-α, IL-1β and IL-6 in milk and plasma  
The variation in cytokine response after the E. coli inoculation was large, but 
significantly elevated concentrations of TNF-α, IL-1β and IL-6 were found in 
milk and plasma from all the infected cows. Except for the mean peak 
concentration of IL-1β in milk (72 hours pi), the mean peak concentrations of all 
cytokines were observed within the first 24 hours pi in both milk and plasma. High 
concentrations of TNF-α, IL-1β and IL-6 in plasma, and TNF-α in milk during the 
E. coli mastitis were associated with more severe clinical signs.  
 
The ex vivo WBAs (Paper III) 
Incubation with LPS and E. coli in the ex vivo WBA stimulated the leukocytes to 
produce TNF-α, IL-1β and IL-6. Elevated levels were observed in blood samples 
after both 3.5 and 24 hours, with highest concentrations of all cytokines at 3.5 
hours. Two cows were ranked high responders for all three cytokines, two were 
ranked low responders for all three cytokines and six were ranked differently for 
the different cytokines. 
Two cows ranked low for all cytokines, one cow ranked high for all cytokines 
and three cows ranked differently for the different cytokines became infected by 
the E. coli inoculation. One cow ranked high for all cytokines, and three cows 
ranked differently depending on cytokine were not infected by the E. coli 
inoculation. No significant differences between the pre-inoculation high and low 
responders and the TNF-α, IL-1β and IL-6 production in milk and plasma pi were 
observed. The diarrhoea score and the heart rate pi differed between the pre-
inoculation high and low groups for IL-1β and IL-6, respectively. 
 
Experimental E. coli LPS and S. aureus PGN mastitis (Paper IV) 
Detectable concentrations of IL-1β, SAA and LBP were found in all plasma 
samples analysed. In both cows the LPS inoculation induced higher concentrations 
of SAA and LBP than the PGN inoculation. IL-1β was found in highest plasma 
concentrations after LPS inoculation in one cow and after PGN inoculation in the 
other cow. LPS induced a peak in the LBP plasma concentration in both cows 
while PGN only induced LBP production in one cow and not the other.   33 
Discussion 
This thesis is focused on development of microsphere based flow cytometric 
assays for detection of bovine markers of inflammation and infection. The reasons 
for this was that well-functioning immunoassays was lacking for immunologically 
interesting markers in different domestic animal species, and that flow cytometric 
microsphere assays previously had been proven successful in studies on rodents 
and humans. In this thesis, the xMAP
 technique was shown to function in bovine 
samples, allowing simultaneous detection of cytokines and APPs. The usefulness 
of the assays designed for bovine samples would be increased with further work 
on assay development. With the continuously expanding range of commercially 
available reagents, this technique has great potential of replacing less versatile 
techniques used today. 
 
Methodological considerations 
Antibody clones cross-reacting between species  
In the field of veterinary immunology, an important problem is the lack of 
reagents for immunoassays. In several cytokine and APP studies on cattle, 
antibodies against ovine or human homologues of the analytes are utilized, and 
human recombinant proteins are often applied as standards (Horadagoda et al., 
1993; Shuster, Kehrli & Stevens, 1993; Bannerman et al., 2003; Grönlund et al., 
2003; Lahouassa et al., 2007; Sohn et al., 2007). Biological cross-reactivity 
between antibodies and cytokines or APPs of different species is evident, for 
instance several commercially available assays are validated for use in multiple 
species (SAA-ELISA, Tridelta Ltd, Maynooth, Ireland; LBP-ELISA, HyCult 
Biotechnology, Uden, Netherlands). The cross-reactivity between antibodies 
against a protein homologue in another species is often not as strong as within a 
species. Therefore, absolute concentrations achieved in such assays should be 
interpreted with caution. The sensitivity is, however, often enough for illustration 
of large concentration changes within animals. 
 
In Paper I, all antibodies tested against human TNF-α could detect rhuTNF-α 
when applied in the xMAP technique, indicating that the technique worked 
satisfactorily. Other studies conducted in our laboratory have proven that the 
xMAP method can be used with reliable results. Successful cytokine 
measurements have been performed in human blood plasma and serum, brain 
tissue from mice and in porcine blood serum and lung lavage (Stricklin & 
Arvidsson, 2004; Johannisson et al., 2006; Tyvold et al., 2008). 
Two of the antibody clones in Paper I identified rovTNF-α while none of the 
evaluated clones detected TNF-α in bovine samples. The detection level of 
rovTNF-α using anti-human TNF-α antibodies was, however, not satisfactory, 
given that cytokines are powerful signal molecules that induce effects at low 
concentrations (Kelso, 1998). The results from Paper I are probably explained by 
inability of the antibody clones to cross-react between species. Antibodies against   34
bovine TNF-α have become available, but this is not yet the case for antibodies 
against many other animal proteins.   
 
Another study where cross-species reactivity of antibodies was investigated was 
conducted by Pedersen et al. (2002). In that study, monoclonal antibodies against 
different human, ovine or bovine cytokines were investigated for their ability to 
detect homologous cytokines produced by blood cells from different species. 
Antibodies directed against ovine TNF-α detected not only ovine TNF-α but also 
TNF-α produced by bovine, caprine, porcine, mink and human cells. The antibody 
clone against IL-6 also cross-reacted between species and could detect ovine, 
bovine, caprine, porcine, canine, mink and human IL-6, although to lesser extent 
than the anti-ovine TNF-α clone.  
The reason that cross-species reactivity between antibodies and homologous 
immunological proteins can occur depends on their high conservation through 
evolution, thus they have similar structures in different species (Syversen et al., 
1994; Scheerlinck, 1999; Soller et al., 2007). In the two latter reports, the origin of 
cytokines in human, mouse, sheep, cow, pig, rat, dog, cat and horse were 
investigated. The conclusions were that more than 60% amino acid homology 
between cytokine homologues usually allowed for cross-reactivity between 
species, and that cross-reactivity was seen more frequently with higher amino acid 
homology. When the coding sequences of IL-1β were compared between the 
species mentioned above, about 70 to 84% identity was observed. Corresponding 
values for TNF-α were 80 to 94%. In the report by Syversen et al. (1994), a high 
degree of homology between SAA from humans, sheep, cow, horse, dog, cat and 
mink, was found. Within the different cytokine and APP genes, some sequences 
are more well-preserved through evolution than others. If these well-preserved 
regions function as active site for antibody binding, proteins with low amino acid 
homology can still have a strong tendency to cross-react. 
 
The xMAP assays 
 
Sensitivity 
LODs of the singleplex assays for TNF-α, IL-1β, SAA and LBP, the duplex assay 
format for IL-1β and the triplex assay for IL-1β, SAA and LBP were lower or 
comparable with other immunoassays used for detection of these analytes in 
bovine samples (Goto et al., 1997; Bannerman et al., 2003; Grönlund et al., 2003; 
Rambeaud et al., 2003; Lehtolainen, Røntved & Pyörälä, 2004). Other assays with 
even lower detection limits for TNF-α, IL-1β and IL-6 have also been reported 
(Rainard & Paape, 1997; Whelan et al., 2003; Molina, 2005).  
During inflammatory responses the pro-inflammatory cytokines are secreted 
transiently and in low concentrations (pg-ng/ml). Therefore, sensitive 
immunoassays with low LODs are necessary. The singleplex assays for TNF-
α, IL-1β and IL-6 developed in Paper II had satisfactory LODs, but that was not 
the case for the duplex and the triplex assays. One reason for this could be that the 
singleplex assays for TNF-α, IL-1β and IL-6 had to be modified in order to design 
a functional multiplex assay. For instance, MFI signals generally increase with 
longer incubation time but at the same time the background noise increases. In the   35 
duplex and triplex analyses the incubation time for IL-6 had to be shortened and 
this meant that the sensitivity for TNF-α and IL-1β were lost due to proportionally 
higher background fluorescence. 
APPs can, unlike cytokines, be found in low but detectable levels (ng-μg/ml) in 
milk and blood plasma from healthy cows (Bannerman et al., 2003; Lehtolainen, 
Røntved & Pyörälä, 2004). In this study the LODs of the APP assays were 
satisfactory and we could show that he triplex xMAP assay for IL-1β, SAA and 
LBP was useful for detailed studies on APPs during inflammatory responses.  
 
Linear range 
During our studies we generally observed wider linear ranges in singleplex assays 
than in duplex or triplex assays, a phenomenon earlier reported for xMAP assays 
(Carson & Vignali, 1999). The linearity of the standard curves for IL-1β was 
similar in the different assays developed in Paper II and IV, supporting the 
robustness and reproducibility reported for the xMAP technique. Multiplex flow 
cytometric assays usually have broader linear ranges than ELISAs (Kellar & 
Iannone, 2002; Jenmalm et al., 2003). Working ranges of ELISAs normally spread 
over one or two orders of magnitude while xMAP assays can have working ranges 
over three or four orders of magnitude. The linearity of the standard curves in the 
different singleplex assays agreed with those findings, although the linear ranges 
for the singleplex assays in Paper IV were not fully explored due to lack of 
sufficient quantities of recombinant proteins. 
In multiplex assays where cytokine and APP detection is combined, the linear 
ranges of the individual assays are important. APPs can be abundant in biological 
fluids and would allow large dilution while cytokines are found only in low 
concentrations. To avoid dilution problems the sensitivity of the different assays 
included in the multiplex assay could be altered. The sensitivity of the APP assays 
could be lowered by coupling fewer antibodies to each microsphere (Dasso et al., 
2002; Sun et al., 2007), making it possible to analyse them together with 
cytokines. 
 
Intra- and inter-assay variation 
Intra- and inter-assay variations of an assay are important measures of the 
precision and reproducibility. Low intra-assay variation allows for less replicates 
on the same plate, which is very valuable when the sample volume is small, and 
also saves time and consumption of reagents. Low inter-assay variation is 
important for comparisons of analysis results performed on different days and in 
studies where repeated analyses are performed over a long time span. 
In the xMAP assays validated here, most CV’s were comparable with values in 
guidelines for analytical procedures and other reports on assay development for 
soluble analytes (Validation of analytical procedures, 1996; Wadhwa & Thorpe, 
1998; Morgan et al., 2004). In some of the multiplex assays, the inter-assay CV’s 
was however higher than recommended. Problems due to high intra- and inter-
assay variation can be reduced by running samples in duplicates and by including 
internal control samples and standard curves in each assay. 
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Cross-reactivity between reagents 
Significant cross-reactivity was not found between any reagents in the multiplex 
xMAP
 assays developed in this thesis. This allows for reliable quantification of 
several analytes in the same sample, with low risk of false positive results. Cross-
reactivity is often a problem in assays where several antibodies and antigens are 
combined in the same solution (Rosner, Grassman & Haas, 1991). This problem is 
especially prominent in veterinary immunology where reagents developed for 
specific species are rare (Shuster, Kehrli & Stevens, 1993; Bannerman et al., 
2003; Lahouassa et al., 2007; Sohn et al., 2007). Yet, the choice of antibody 
clones is most important. In addition, assay buffers, incubation times and 
temperatures, blocking components and sample diluents also have a large 
influence (de Jager & Rijkers, 2006). In a sandwich immunoassay, the specific 
binding of antibodies to an analyte is utilized. Monoclonal antibodies are often 
used for the detection of an analyte as distortions due to other molecules become 
minimized. The concentration of bound analyte is often determined by polyclonal 
antibodies, as their broad range of epitopes increases the chances of detecting all 
analytes bound to the monoclonal antibodies. 
 
Matrix effects   
In the recovery experiment performed in Paper I, rhuTNF-α added to bovine milk 
or serum samples was detected to a lower degree compared to quantifications in 
buffer, indicating a quenching effect of the milk and serum. In Paper II, a general 
reduction of MFI was observed when samples were analysed in multiplex assays 
compared with singleplex assays. Similar findings were seen in Paper IV, but to a 
lesser extent than in Paper II. Those findings concur with results acquired e.g. by 
Carson & Vignali (1999). The reduced MFI is probably due to cross-reactivity 
between different host derived antibodies, the recombinant proteins and other 
components in the biological samples. 
 
Quenching of fluorescent signals has previously been observed in immunoassays 
(Mire-Sluis, Gaines-Das & Thorpe., 1995; Selby, 1999; Phillips et al., 2006). 
When immunoassays are performed in e.g. milk and blood plasma samples, 
endogenous antibodies, soluble receptors and anti-cytokine antibodies may 
interfere and disturb the results of the assay, leading to both false positive and 
false negative values. The composition of milk from cows with mastitis may 
diverge depending on the phase of the inflammation (Pyörälä, 2003; Berglund et 
al., 2007), which means that recovery of analytes may differ widely. This could be 
one explanation why the recovery of rhuTNF-α was low in Paper 1.  
Recovery of recombinant human cytokines added to blood serum have been 
found to be concentration dependent, and high non-physiological concentrations 
were recovered to a larger extent than concentrations in a physiologically expected 
range (Prabhakar et al., 2004). These and many other data show the importance of 
validating each assay using the intended matrix. During mastitis, the composition 
of milk becomes strongly altered, and validation of a general assay for use in milk 
from cows with mastitis can be difficult. 
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False positive signals are often caused by heterophile antibodies making bridges 
between capture and detection antibodies (Phillips et al., 2006). When an analyte 
binds to soluble receptors or auto-antibodies in biological samples the 
concentration of an analyte is underestimated (Boscato & Stuart, 1988; Phillips et 
al., 2006). Such false negative results have been reported for of TNF-α, IL-1β and 
IL-6 in human blood plasma and serum, and in synovial fluid (Svensson et al., 
1993; de Jager & Rijkers, 2006), but could also be expected to occur in bovine 
samples. Since physical barriers between vessel walls and the surrounding tissue 
are destroyed during many inflammatory responses, components of plasma can be 
found for instance in milk during mastitis (Rainard, 2003). Problems with soluble 
receptors and heterophile antibodies could therefore be expected in milk samples 
from cows with mastitis. Problems with matrix effects can to some extent be 
reduced by dilution.  
 
The WBA as a predictive tool 
The looser consistency of faeces and higher heart rate pi found in the pre-
inoculation low responders for IL-1β and IL-6, were not enough to suggest that 
those groups were more susceptible to severe forms of E. coli mastitis than the 
high responders for IL-1β and IL-6. Differences in kinetics of bacterial clearance 
in milk, other clinical symptoms and in vivo cytokine concentrations pi were not 
observed between any of the pre-inoculation high and low groups, thus the WBAs, 
performed in their present form, could not be considered useful predictive tools for 
the clinical outcome of a following E. coli mastitis. 
 
A reason that the TNF-α, IL-1β and IL-6 WBAs did not work as predictive tools 
of the severity of E. coli mastitis could be the LPS doses and incubation times 
which were used. In previous WBA studies, the aim has been to induce maximum 
response of the cytokines, most prevalently TNF-α, ex vivo, for comparisons with 
processes  in vivo (Hutchinson et al., 1999; Wurfel et al., 2005). In order to 
determine the maximum response, studies on doses have been performed, and the 
TNF-α response seems to be dose dependent up to the level where the maximum 
response is reached (Finch-Arietta and Cochran, 1991; Foster et al., 1993; 
Nakamura, Nitta & Ishikawa, 2004; Røntved et al., 2005). In human, bovine and 
porcine blood samples, the maximum TNF-α response to LPS has been observed 
after 2 to 8 hours stimulation (Allen et al., 1992; Carstensen et al., 2005; Røntved 
et al.,  2005). In the WBA performed in Paper III, a LPS dose previously 
determined to induce maximum TNF-α response in bovine blood (Røntved et al., 
2005) was used, and our results corroborate the earlier studies, as higher TNF-α 
concentrations were found after 3.5 hours than after 24 hours stimulation. In order 
to determine the time point and LPS concentrations for maximum IL-1β and IL-6 
responsiveness to LPS, further studies are needed. Thereafter, customized studies 
using the maximum response of IL-1β and IL-6 in the WBA method might be 
used as predictive tools for the immunological response to an infection.  
The cytokine responsiveness may also be influenced by physiological status of 
the cow. Parturition, metabolic status, and lactation phase have been observed to 
affect the production of pro-inflammatory cytokines (Doherty et al., 1994; 
Sordillo, Pighetti & Davis, 1995). Impaired immunological changes in cattle   38
around parturition have been demonstrated in both in vivo studies (Mallard et al., 
1997) and ex vivo TNF-α responsiveness studies (Røntved et al., 2005). The latter 
study implicates that results from ex vivo WBAs can be useful for monitoring the 
in vivo innate immune system of cows if the right conditions and design is used. 
 
Although ex vivo WBAs are designed to mimic the natural environment for the 
immune system as whole blood is used, data from studies performed outside an 
animal should always be interpreted and translated to in vivo situations with 
caution. The regulation of immunological responses is complicated and can not 
solely be explained by the cytokine levels in blood samples. The production rate 
and source of the cytokines, clearance dynamics, presence of circulating soluble 
receptors for cytokines and LBP, and membrane receptor distribution and their 
activity all contribute to the impact, shape, magnitude and duration of cytokine 
responses to LPS (Koj, 1996; Krishnaswamy et al., 1999).  
 
Experimental infection designs 
To reach the aims of this thesis, milk and blood samples from cows with clinical 
mastitis were needed, and samples from three different experimental mastitis 
studies have been utilized. In Papers I-II and IV, the focus was on development 
and application of the xMAP technique in bovine samples, therefore those 
experimental designs will not be discussed further.  
In Paper III, however, the focus was on monitoring the effects of the 
experimentally induced E. coli infection in the cow in relation to the WBAs 
performed before the infection was induced. However, only six of ten cows 
became infected by the E. coli inoculation and developed clinical mastitis. With 
that small number of cows it is difficult to draw conclusions from the results of the 
ex vivo WBA experiments as a predictive tool of severity of the E. coli infection. 
 
 
Cytokines and APPs in bovine milk and plasma 
Secretion of pro-inflammatory cytokines in biological fluids has been reported in a 
range of bovine mastitis studies, and TNF-α, IL-1β and IL-6 have been suggested 
as important mediators (Shuster, Kehrli & Baumrucker, 1995; Shuster et al., 1997; 
Riollet, Rainard & Poutrel, 2000; Bannerman et al., 2004; Sohn et al., 2007). 
Major APPs and other inflammatory markers, e.g. SAA, haptoglobin, LBP, ITIH4 
(inter-alpha-trypsin inhibitor heavy chain 4) and C5a, have also been detected in 
biological fluids in cows with mastitis (Shuster et al., 1997; Hirvonen et al., 1999; 
Grönlund et al., 2003; Bannerman et al., 2004; Lehtolainen, Røntved & Pyörälä, 
2004; Piñeiro et al., 2004). Our results from the TNF-α, IL-1β, IL-6, SAA and 
LBP analyses in Paper II – IV corroborate earlier studies as all used analytes could 
be detected in milk or blood from cows with mastitis. 
As mentioned earlier, the production of the cytokines and APPs vary between 
inflammatory responses and the physiological status of the host. More severe cases 
of  E. coli mastitis are often reported around calving, in early lactation and at 
drying-off (reviewed by Burvenich et al., 2003). High concentrations of TNF-α in 
serum were correlated with severe mastitis, sepsis and death in some studies   39 
(Sordillo & Peel, 1992; Hirvonen et al., 1999; Blum et al., 2000; Hisaeda et al., 
2001), while other studies did not report such associations (Nakajima et al., 1997; 
Hoeben et al., 2000). Our results from Paper III agree with the latter studies as the 
cows which developed moderate mastitis had elevated TNF-α levels in both milk 
and plasma. 
 
Other factors than the physiological status of a cow influence the cytokine and 
APP concentrations in milk and blood during experimentally induced mastitis. The 
choice and dose of stimuli is important. The clearance of structural components of 
bacteria, e.g. LPS, PGN or LTA, would presumably be easier than clearance of 
proliferating bacteria in the udder. Thus, live pathogens are expected to induce 
longer lasting immunological responses than bacterial components, which were 
supported by a comparative study on E. coli and LPS mastitis performed by Blum 
et al. (2000).  
When bacteria were used to induce mastitis, increased mRNA expression or 
secretion of TNF-α, IL-1β, IL-6, SAA and LBP in milk and blood have been 
reported (Shuster et al., 1997; Eckersall et al., 2001; Bannerman et al., 2004; 
Vangroenweghe et al., 2005; Hyvönen et al., 2006; Lahouassa et al., 2007). In 
studies where E. coli LPS, S. aureus LTA or α-toxin were used to induce mastitis, 
pro-inflammatory cytokines and APPs were frequently detected in milk but 
seldom in blood (Shuster, Kehrli & Stevens, 1993; Rainard & Paape, 1997; 
Lehtolainen, Røntved & Pyörälä, 2004). The TNF-α response in milk and blood 
during LPS mastitis has been shown to be local and regulated within the mammary 
gland (Rainard & Paape, 1997; Paape et al., 2002; Lehtolainen, Røntved & 
Pyörälä, 2004). Taken together, the results suggest that the immunological 
response is systemically activated and regulated to a larger extent during bacterial 
udder invasion than when only fragments of bacteria are present.  
In samples from the experimental E. coli mastitis study in Papers II and III, IL-
1β and IL-6 were detected at least once in milk and plasma samples from all six 
infected cows. TNF-α concentrations were found at least once in milk samples 
from all the infected cows and in plasma from four of the infected cows. Our data 
from Papers II-III indicate that TNF-α, IL-1β and IL-6 are involved in the local 
inflammatory response to E. coli bacteria in the udder, as well as in the systemic 
immune response to the invading pathogen, which concur with the results 
discussed above. In Paper IV, plasma from only two cows were analysed, and 
conclusions are difficult to draw. However, in accordance with previous studies, 
SAA and LBP were detected in plasma samples collected after endotoxin 
inoculation (Bannerman et al., 2003; Lehtolainen, Røntved & Pyörälä, 2004). Also 
the PGN inoculation induced elevated SAA and LBP levels. The SAA plasma 
concentration increased two- to fiftyfold during mastitis, while LBP 
concentrations became doubled after both inoculations.  
 
The initiation and regulation of early immune responses are not fully explored but 
the production of TNF-α, IL-1β and IL-6 seems to be closely related, and the 
cytokines can probably influence the production of each other (Moshage, 1997; 
Gruys et al., 2005). Our results agree with that theory.  
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In Paper III, we saw that high plasma concentrations of IL-1β were associated 
with high IL-6 and TNF-α plasma concentrations within the cow. In addition, high 
concentrations of TNF-α in milk and plasma tended to be associated with each 
other. The mean peak concentrations of TNF-α, IL-1β and IL-6 in plasma and the 
mean peak concentration of TNF-α in milk were observed at the same time point 
as fever, elevated heart rate and changes in milk colour occurred in the infected 
cows. Other E. coli mastitis studies have been reported where peak concentrations 
of the pro-inflammatory cytokines in milk and plasma were concurrent with onset 
of clinically visible symptoms (Sordillo & Peel, 1992; Bannerman et al., 2004). In 
a study by Lehtolainen, Røntved & Pyörälä (2004), the milk concentrations of 
TNF-α and SAA after intramammary LPS inoculation seemed to be associated 
with each other and with the clinical signs. The results in Paper III concur with 
results from that study, where elevated milk TNF-α concentrations were found to 
be associated with local udder symptoms and changed milk parameters. In 
addition, high plasma levels of TNF-α, IL-1β and IL-6 were associated with fever, 
elevated heart rate, looser faeces consistency, reduced milk yield, changed milk 
colour and swollen and red udder.  
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Conclusions 
•  Commercially available antibodies against human TNF-α did not cross-
react with bovine TNF-α when applied in the xMAP assay. Two clones 
of anti-human TNF-α antibodies cross-reacted with recombinant ovine 
TNF-α in concentrations above 2.5 ng/ml. 
 
•  TNF-α, IL-1β and IL-6 could be detected in bovine milk and plasma with 
singleplex, duplex and triplex xMAP
  assays using ovine and bovine 
reagents. The singleplex xMAP
 assays for TNF-α, IL-1β and IL-6 could 
be applied to monitor cytokines in milk and plasma from cows with E. 
coli  mastitis. In order to be a valuable tool in studies where low 
concentrations of TNF-α, IL-1β and IL-6 are of interest, the triplex 
xMAP assay need further development work.   
 
•  Ex vivo WBAs using LPS and E. coli induced production of TNF-α, IL-
1β and IL-6. The cytokine concentrations in the pre-inoculation blood 
samples, induced by the LPS and E. coli doses and incubation times used, 
could not predict the severity of an E. coli induced mastitis. 
 
•  In cows, which had developed mastitis after intramammary inoculation of 
E. coli, high blood plasma concentrations of TNF-α, IL-1β and IL-6, and 
high milk TNF-α concentrations were associated with more severe 
clinical symptoms. 
 
•  The cytokine IL-1β and the acute phase proteins SAA and LBP could be 
detected in bovine plasma from cows inoculated with LPS and PGN 
using singleplex and triplex xMAP assays. 
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Future perspectives 
The development of microsphere based flow cytometric assays for multiplex 
analysis of human analytes has been rapid. From being able to analyse six 
cytokines simultaneously in 1999 (Chen et al., 1999), more than 50 cytokines 
were detected simultaneously seven years later (Elshal & McCoy, 2006). During 
the last year an equine anti-virus antibody xMAP assay has been reported (Go et 
al., 2008). With this progress, it is plausible to believe that microsphere based 
flow cytometric assays will be applied in new areas of veterinary medicine during 
the next years. 
Predicting in which areas of veterinary medicine the xMAP technique will be 
applied is difficult mainly because the accessibility to reagents is limited. Below, a 
few thoughts on how our existing xMAP panels could be expanded, and some 
examples on where development of xMAP panels would be valuable are presented 
and discussed.  
 
In Paper IV, the triplex assay for IL-1β, SAA and LBP was validated for blood 
plasma but with further validation work, the assay can be applied in any biological 
fluid,  e.g. saliva, lung lavage, blood or faeces, depending on the type of 
information wanted. LBP is only present in high concentrations during bacterial 
infections and therefore serves as a good marker of such infections. By adding a 
marker for virus, our assay would contribute more information about the origin of 
a disease. Production of Type 1 interferons (IFN-α and IFN-β) is induced as a 
response to presence of virus or double-stranded DNA in a host (Sandberg, 
Matsson & Alm, 1990; Haller, Kochs & Weber, 2006), making them good 
markers of viral infections. For example, serum concentrations of IFN-α and IL-6 
were used as markers of ongoing viral and bacterial infections in pigs (Le 
Bonnardiere & Laude, 1981; Fossum et al., 1998). Thus it is feasible to use the 
xMAP panel in other domestic species than cows. Other options for detection of 
viral infections could be IFN-γ inducible protein (IP-10/CXCL10), which is 
directly induced by IFN-α and IFN-β (Gangur, Birmingham & Thanesvorakul, 
2002), or Mx proteins which are produced in cells stimulated with IFN-α 
(Horisberger & Gunst, 1991). Simultaneous detection of IL-1β, SAA and IFN-α 
can be performed in our laboratory (Dernfalk, Persson Waller & Johannisson, 
2006), but at present the lack of IFN-α reagents makes further work with that 
panel impossible.  
Bacterial and viral infections traditionally elicit different immunological 
responses, but cross-talk between immunological pathways occurs and therefore 
immunological markers used to differentiate between viral and bacterial infections 
should be regarded with caution. 
 
Health problems and economical losses due to infections are evident in many 
animal species. An example is bacterial dysentery infections which convey high 
mortality in growing pigs (Raynaud, Brunault & Philippe, 1980). In order to 
develop prophylactic measures and vaccination programmes for dysentery in pigs, 
an understanding of the host immune responses during the disease is essential. 
Johannisson et al. (2006) reported of development of a triplex xMAP assay for   43 
simultaneous detection of TNF-α, IL-1β and IL-8 in porcine blood plasma and 
serum, which could provide useful information if applied in biological samples 
from pigs with dysentery. If this xMAP assay for porcine cytokines was expanded 
with IL-6 and SAA, also information about the acute phase response would be 
achieved.  
Pigs are used as model animals in comparative studies with humans, for instance 
in the research on lung diseases. The porcine cytokine xMAP assay developed by 
Johannisson et al. (2006) was used to continuously monitor cytokines in bronchial 
epithelial fluid collected by microdialysis in pigs (Tyvold et al., 2008). It is 
planned to expand the xMAP panel to include the pro-inflammatory cytokine IL-6, 
the anti-inflammatory cytokine IL-10 and the modulating cytokine IFN-γ to 
increase the understanding of the inflammatory responses to lung injury or 
infection.  
 
The majority of reports with xMAP assays are published within the field of 
immunology, although applications many other areas are possible (Morgan et al., 
2004; Elshal & McCoy 2006). An area attracting considerable interest in the 
human research field is at the moment obesity and its connections to development 
of type-2 diabetes, cardiovascular disease and correlations to increased risk of 
cancer (Lawrence & Kopelman, 2004). Studies on the interactions between 
nutrition, endocrinology and metabolism also become increasingly important in 
our domestic animals. For instance, race horses and dairy cows demand optimal 
nutrition, and obesity among pets is an increasing problem. Therefore an xMAP 
assay for simultaneous detection of proteins involved in hormonal metabolic 
signalling at circulation and at tissue levels could be designed for different animal 
species. Metabolic xMAP analyses are available for many human metabolic 
steroids and proteins (Yurkovetsky, 2007). 
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Swedish summary 
Populärvetenskaplig sammanfattning 
Infektioner hos nötkreatur är ett stort problem i hela världen. Mastit 
(juverinflammation) orsakas oftast av att juvret invaderas av bakterier och trots att 
det har gjorts otaliga försök att kartlägga orsakerna till och förloppet av mastit är 
sjukdomen fortfarande ett allvarligt problem. Studier för att fördjupa kunskaperna 
om mastit, utveckla förebyggande åtgärder, diagnostiska metoder eller hitta 
alternativa behandlingsvägar är därför ständigt aktuella. 
 
När juvret invaderas av sjukdomsframkallande mikroorganismer startas ett 
immunsvar i kon. Genom att mäta koncentrationsförändringar av de protein som 
reglerar immunsvaret kan man studera infektionsförloppet vid mastit. De 
reglerande proteinerna kallas cytokiner och är immunförsvarets budbärare. Olika 
grupper av cytokiner har olika funktioner, vissa aktiverar medan andra hämmar 
immunsvaret. Det är viktigt att det finns en balans mellan de aktiverande och de 
hämmande cytokinerna så att ett immunsvar varken blir för kraftigt eller för svagt. 
Akutfasproteiner är en annan grupp viktiga proteiner i immunförsvaret. De 
tillverkas i levern när immunförsvaret aktiveras och de kan både stimulera och 
hämma immunsvaret. Att de kan användas som markörer för inflammation beror 
på att deras koncentrationer i blodserum ofta ökar dramatiskt vid inflammationer. 
Möjligheten att mäta koncentrationer av cytokiner och akutfasproteiner i 
biologiska prover är fundamental i forskning kring immunsvar mot infektioner. 
Ett exempel på hur man kan mäta immunologiskt viktiga protein är med den 
flödescytometribaserade xMAP-tekniken. Flödescytometri är en teknik där 
partiklars egenskaper bestäms via det ljus de sänder ut efter att ha blivit belysta av 
en laser. I xMAP-analyser fångas den analyt man vill mäta mellan två antikroppar 
riktade mot olika delar av analyten. De antikroppar som ska fånga in analyten 
kopplas till små plastkulor (mikrosfärer) som blandas med det biologiska provet. 
Om det finns analyter av intresse i provet binder de in till antikropparna på 
kulorna. Ett mått på mängden inbunden analyt fås genom att fluorescensinmärkta 
antikroppar sätts till lösningen innan proverna analyseras i en flödescytometer. För 
att kunna mäta flera olika analyter samtidigt i samma prov används mikrosfärer 
med unika färgkombinationer. xMAP-tekniken har visat sig användbar inom 
många områden, bland annat för analys av cytokiner, antikroppar, 
ämnesomsättningsenzym, intracellulära proteiner och cancermarkörer.  
. 
Syftet med den här avhandlingen var att utveckla xMAP-analyser för 
inflammatoriska markörer vars koncentrationer ökar vid inflammationer i kor. 
Fokus låg på utveckling av analyser för cytokiner och akutfasproteiner i mjölk och 
blod från kor med mastit.  
För att uppnå syftet designades xMAP-analyser för att studera en (singleplex), 
två (duplex), eller tre (triplex) analyter samtidigt. Analyser för cytokinerna tumour 
necrosis factor (TNF)-α, interleukin (IL)-1β och IL-6 samt för akutfasproteinerna 
serum amyloid A (SAA) och lipopolysaccharide binding protein (LBP) 
utvecklades. Metoderna validerades enligt riktlinjer för immunologiska metoder.   45 
För varje xMAP-analys bestämdes lägsta detektionsgräns, inom vilka 
koncentrationer analyserna var tillförlitliga samt variation inom och mellan olika 
analystillfällen. I de multiplexa (duplexa och triplexa) analyserna kontrollerades 
även eventuell korsreaktivitet mellan reagenser, dvs om detektion av en analyt 
ledde till att en ökad koncentration av en annan analyt felaktigt registrerades. 
Att en analys har låg detektionsgräns är främst viktigt i cytokinstudier eftersom 
de är mycket kraftfulla mediatorer och därför bara utsöndras i låga koncentrationer 
under inflammatoriska svar. De singleplexa cytokinanalyserna hade 
tillfredsställande känslighet, men inte de multiplexa analyserna. När det gäller 
akutfasproteinanalyser krävs oftast inte lika låga detektionsnivåer, istället är 
analysens räckvidd viktigare eftersom akutfasproteiner kan förekomma i både låga 
och mycket höga koncentrationer. Räckvidden för tillförlitlig 
koncentrationsbestämning av SAA och LBP var tillfredsställande, men bör kunna 
förbättras ytterligare. Korsreaktivitet noterades inte mellan några av reagenserna i 
de duplexa och triplexa xMAP-analyserna.     
De singleplexa och multiplexa analyserna utvecklade i den här avhandlingen 
kunde användas för detektion av analyterna i mjölk- och blodplasmaprover från 
kor med mastit. Komponenter i mjölk och plasma påverkade detektionen av 
analyter vilket är ett mycket vanligt problem som till viss del går att åtgärda med 
spädning av provet. I en av studierna visade vi att xMAP-tekniken kunde 
användas för att mäta ett cytokin och två akutfasproteiner i samma prov, något 
som kan ge ett tidsperspektiv på ett inflammationsförlopp, eftersom cytokiner 
främst utsöndras i början av en inflammation medan förhöjda koncentrationer av 
akutfasproteiner kan mätas under längre tid. 
 
I en av avhandlingens studier inokulerades tio kor med bakterien Escherichia (E.) 
coli i juvret, vilket ledde till att sex av djuren fick mastit. Innan den experimentella 
mastitstudien genomfördes togs blodprover från korna. Dessa stimulerades med E. 
coli och en komponent som finns i bakteriens vägg kallad lipopolysackarid. När 
blodprover stimuleras kallas det för ex vivo stimulering. Efter ex vivo 
stimuleringen kunde TNF-α, IL-1β och IL-6 mätas i blodet. Kornas förmåga att 
producera cytokiner ex vivo jämfördes med deras immunförsvars förmåga att 
hantera inokulationen av E. coli i juvret. Vi såg att kor som producerade låga 
koncentrationer av IL-1β eller IL-6 ex vivo hade högre  tendens att utveckla diarré 
respektive hade högre puls än vad grupperna som producerade höga nivåer av IL-
1β eller IL-6 hade. Inga andra skillnader i kliniska symptom under infektionen 
sågs mellan kor som ex vivo hade producerat höga och låga koncentrationer av 
cytokinerna. Ex vivo stimuleringen utförd på det här sättet kunde därför inte anses 
vara ett värdefullt verktyg för att förutsäga svårighetsgraden av E. coli-mastiter.  
 
Vid analyser av cytokiner i mjölk och plasma samlat från korna efter E. coli 
inokuleringen observerades att höga plasmanivåer av IL-1β hade samband med 
höga plasmakoncentrationer av TNF-α och IL-6. Dessutom kunde höga TNF-α, 
IL-1β och IL-6 plasmakoncentrationer och höga TNF-α koncentrationer i mjölk 
associeras med kliniska symptom både lokalt och systemiskt. Dessa resultat 
stämmer väl överens med tidigare cytokinstudier på kor med mastit och visar 
xMAP-metodernas användbarhet.   46
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